Study on the Safety and Benefits of Jambusaar-M 100 tablet as an additional treatment for Type 2 Diabetes

A Pilot Exploratory clinical study to evaluate the safety and efficacy of Jambusaar- M 100 tablet as an add-on treatment in the patients with type- 2 Diabetes Mellitus - NIL

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/11/076770

Enrollment

Registered

2024-11-13

Start date

Unknown

Completion date

Unknown

Last updated

2024-12-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E119- Type 2 diabetes mellitus without complications

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: Clinically diagnosed Type 2 DM disorder participants Fasting Blood Sugar Range between 100 to 150 mg per dL Post Prandial Blood Sugar Range between 140 to 300 mg per dL HbA1c Range between 5.7 to 10 Patients Body Mass Index BMI between 18.5 and 35 kg per mt square Patients on allopathic medication for Type 2 DM who can provide 3 months of symptom data, along with FBS, PPBS, and at least one HbA1c report

Exclusion criteria

Exclusion criteria: Patient who is known case of Type-1 Diabetes mellitus. Individuals with known allergies to the Disease specific. Pregnant or breastfeeding women. Individuals with associated comorbidities. Recent participation in another clinical trial. Use of medications known to interact with the study drug. Patients with acute complications like Hyperglycemic coma, Ketoacidosis and Gangrene.

Design outcomes

Primary

Measure	Time frame
changes in DSC-R symptom Score of Type 2 Diabetes MellitusTimepoint: 12 weeks	—

Secondary

Measure	Time frame
Changes in fasting blood glucose levels. Impact on postprandial blood glucose levels. Reduction in Glycated Haemoglobin (HbA1c) levels Timepoint: 12 weeks	—

Countries

India

Contacts

Public ContactDr Radhikaba P Zala

Dr. D. Y. Patil College of Ayurved & Research Centre, Pimpri, Pune, Maharashtra, India-411018

shital.rasane@dpu.edu.in9503330831

Outcome results